Bonraybio Co., Ltd. (6955.TWO)
TWD 141.5
(N/A%)
TWD 141.5
(N/A%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 159.64 Million | 106.27 Million | 56.29 Million | 26.59 Million |
| Cost of Revenue | 39.85 Million | 25.68 Million | 16.71 Million | 5.04 Million |
| Gross Profit | 119.79 Million | 80.59 Million | 39.57 Million | 21.54 Million |
| Operating Expenses | 98.45 Million | 87.23 Million | 78.07 Million | 70.7 Million |
| Selling, General and Administrative Expenses | 57.33 Million | 47.72 Million | 34.24 Million | 31.43 Million |
| Research and Development Expenses | 41.11 Million | 39.5 Million | 43.83 Million | 39.26 Million |
| Other Expenses | - | 7.04 Million | 6.44 Million | 7.58 Million |
| Cost and Expenses | 138.3 Million | 112.91 Million | 94.79 Million | 75.74 Million |
| Operating Income | 21.34 Million | 1.86 Million | -38.5 Million | -49.15 Million |
| Interest Expense | 218 Thousand | 153 Thousand | 209 Thousand | 225 Thousand |
| Income Tax Expense | 25 Thousand | 24 Thousand | 22 Thousand | -13 Thousand |
| Earnings before Tax | 25.75 Million | 1.71 Million | -31.69 Million | -41.17 Million |
| Net Income | 25.72 Million | 1.68 Million | -31.71 Million | -41.15 Million |
| Earnings Per Share Basic | 1.30 | 0.10 | -2.28 | -2.09 |
| Earnings Per Share Diluted | 1.30 | 0.10 | -2.28 | -2.08 |
| Weighted Average Shares Outstanding | 19.73 Million | 17.78 Million | 13.9 Million | 19.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 19.77 Million | 17.79 Million | 13.9 Million | 19.77 Million |
| Gross Margin | 0.75 | 0.76 | 0.70 | 0.81 |
| EBIT Margin | 0.23 | 0.11 | -0.36 | -1.07 |
| Profit Margin | 0.16 | 0.02 | -0.56 | -1.55 |
| EBITDA | 36.61 Million | 11.37 Million | -20.22 Million | -28.52 Million |
| Earnings Before Tax Margin | 0.13 | 0.02 | -0.68 | -1.85 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 54.63 Million | 48.17 Million | 159.64 Million | 30.17 Million | 33.76 Million | 106.27 Million |
| Cost of Revenue | 10.9 Million | 10.46 Million | 39.85 Million | 6.55 Million | 8.3 Million | 25.68 Million |
| Gross Profit | 43.72 Million | 37.7 Million | 119.79 Million | 23.61 Million | 25.45 Million | 80.59 Million |
| Operating Expenses | 29.06 Million | 26.19 Million | 98.45 Million | 22.53 Million | 22.93 Million | 87.23 Million |
| Selling, General and Administrative Expenses | 17.86 Million | 16.44 Million | - | 12.92 Million | 12.7 Million | - |
| Research and Development Expenses | 11.2 Million | 9.74 Million | - | 9.61 Million | 10.23 Million | - |
| Other Expenses | 780 Thousand | 2.08 Million | 1.61 Million | 1.21 Million | 13 Thousand | 7.04 Million |
| Cost and Expenses | 39.96 Million | 36.65 Million | 138.3 Million | 29.09 Million | 31.24 Million | 112.91 Million |
| Operating Income | 16.53 Million | 14.31 Million | 25.96 Million | 3.27 Million | 2.91 Million | 1.86 Million |
| Interest Expense | 44 Thousand | 48 Thousand | 218 Thousand | 56 Thousand | 59 Thousand | 153 Thousand |
| Income Tax Expense | 26 Thousand | - | 25 Thousand | 1000.00 | 24 Thousand | 24 Thousand |
| Earnings before Tax | 16.49 Million | 14.26 Million | 25.75 Million | 3.21 Million | 2.85 Million | 1.71 Million |
| Net Income | 16.46 Million | 14.26 Million | 25.72 Million | 3.21 Million | 2.82 Million | 1.68 Million |
| Earnings Per Share Basic | 0.73 | 0.72 | - | 0.16 | 0.15 | - |
| Earnings Per Share Diluted | 0.73 | 0.72 | - | 0.16 | 0.15 | - |
| Weighted Average Shares Outstanding | 22.64 Million | 19.73 Million | 19.73 Million | 19.73 Million | 19.73 Million | 17.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.64 Million | 19.77 Million | 19.77 Million | 19.77 Million | 19.76 Million | 17.79 Million |
| Gross Margin | 0.80 | 0.78 | 0.75 | 0.78 | 0.75 | 0.76 |
| EBIT Margin | 0.36 | 0.36 | - | 0.20 | 0.16 | - |
| Profit Margin | 0.30 | 0.30 | 0.16 | 0.11 | 0.08 | 0.02 |
| EBITDA | 19.48 Million | 17.31 Million | - | 5.93 Million | 5.43 Million | - |
| Earnings Before Tax Margin | 0.30 | 0.30 | 0.16 | 0.11 | 0.09 | 0.02 |
JAN
CCRRF
000037
PROF-B
102260
MARKOLINES